Biotech investors and executives are expected to flock to San Francisco for a set of annual conferences in January. The Biotech Showcase has grown into a critical meeting to start the new year. With concerns about the pandemic receding, it is already attracting a large number of registrations. This year’s event offers a rich agenda and will include the Digital Medicine & Medtech Showcase the Asia Showcase, and the Seed Showcase. We spoke to Sara Demy, founder and CEO of Demy-Colton, which co-produces the Biotech Showcase with the EBD Group, about what’s in store at this year’s event, the large number of partnering meetings that are already scheduled, and what participants can do to get the most out of the conference.
